Only one class of chemotherapy, namely taxanes, is effective against prostate cancer, the second leading cause of cancer for men in the United States. A study published online this week (January 17th) in Clinical Cancer Research, researchers have found that a newer member of the taxane family called cabazitaxel, an FDA approved drug, has properties that could make it more effective for some patients - a hypothesis currently being tested in clinical trials. Researchers ...
You have just read an article categorized health
titled New Study Reveals How to Improve Chemotherapy Use in Prostate Cancer.
Written by:
editor - Monday, February 16, 2015
There are currently no comments for "New Study Reveals How to Improve Chemotherapy Use in Prostate Cancer"
Post a Comment